Loading…

Extrasynaptic GABAA Receptors: Form, Pharmacology, and Function

GABA is the principal inhibitory neurotransmitter in the CNS and acts via GABA(A) and GABA(B) receptors. Recently, a novel form of GABA(A) receptor-mediated inhibition, termed "tonic" inhibition, has been described. Whereas synaptic GABA(A) receptors underlie classical "phasic" G...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of neuroscience 2009-10, Vol.29 (41), p.12757-12763
Main Authors: Belelli, Delia, Harrison, Neil L, Maguire, Jamie, Macdonald, Robert L, Walker, Matthew C, Cope, David W
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 12763
container_issue 41
container_start_page 12757
container_title The Journal of neuroscience
container_volume 29
creator Belelli, Delia
Harrison, Neil L
Maguire, Jamie
Macdonald, Robert L
Walker, Matthew C
Cope, David W
description GABA is the principal inhibitory neurotransmitter in the CNS and acts via GABA(A) and GABA(B) receptors. Recently, a novel form of GABA(A) receptor-mediated inhibition, termed "tonic" inhibition, has been described. Whereas synaptic GABA(A) receptors underlie classical "phasic" GABA(A) receptor-mediated inhibition (inhibitory postsynaptic currents), tonic GABA(A) receptor-mediated inhibition results from the activation of extrasynaptic receptors by low concentrations of ambient GABA. Extrasynaptic GABA(A) receptors are composed of receptor subunits that convey biophysical properties ideally suited to the generation of persistent inhibition and are pharmacologically and functionally distinct from their synaptic counterparts. This mini-symposium review highlights ongoing work examining the properties of recombinant and native extrasynaptic GABA(A) receptors and their preferential targeting by endogenous and clinically relevant agents. In addition, it emphasizes the important role of extrasynaptic GABA(A) receptors in GABAergic inhibition throughout the CNS and identifies them as a major player in both physiological and pathophysiological processes.
doi_str_mv 10.1523/JNEUROSCI.3340-09.2009
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2784229</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67694023</sourcerecordid><originalsourceid>FETCH-LOGICAL-h212t-69a468f7c71775a862481a32e025ea52ad5985a68a70bc4ac3caa8f8542a6e7e3</originalsourceid><addsrcrecordid>eNpVkMtOwzAQRS0EgvL4BZQVYkGKPXH8YAEqVQtFiCIea2vquk1QEpc4pfTviURBsJrFPTr3agg5ZrTLUkjO7x4Gr0_j5_6omyScxlR3gVK9RTptqmPglG2TDgVJY8El3yP7IbxRSiVlcpfsMa1ASSU65Grw2dQY1hUumtxGN73rXi96ctYtGl-Hi2jo6_IsesywLtH6ws_XZxFW02i4rGyT--qQ7MywCO5ocw_I63Dw0r-N78c3o37vPs6AQRMLjVyombSSSZmiEsAVwwQchdRhCjhNtUpRKJR0YjnaxCKqmUo5oHDSJQfk8tu7WE5KN7WuamcXZlHnJdZr4zE3_5Mqz8zcfxiQigPoVnCyEdT-felCY8o8WFcUWDm_DEZIoTmFpAWP_zb9Vvz8rAVOv4Esn2ervHYmlFgULc7MarUCbTgzDGQqky_0TX24</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67694023</pqid></control><display><type>article</type><title>Extrasynaptic GABAA Receptors: Form, Pharmacology, and Function</title><source>PubMed (Medline)</source><creator>Belelli, Delia ; Harrison, Neil L ; Maguire, Jamie ; Macdonald, Robert L ; Walker, Matthew C ; Cope, David W</creator><creatorcontrib>Belelli, Delia ; Harrison, Neil L ; Maguire, Jamie ; Macdonald, Robert L ; Walker, Matthew C ; Cope, David W</creatorcontrib><description>GABA is the principal inhibitory neurotransmitter in the CNS and acts via GABA(A) and GABA(B) receptors. Recently, a novel form of GABA(A) receptor-mediated inhibition, termed "tonic" inhibition, has been described. Whereas synaptic GABA(A) receptors underlie classical "phasic" GABA(A) receptor-mediated inhibition (inhibitory postsynaptic currents), tonic GABA(A) receptor-mediated inhibition results from the activation of extrasynaptic receptors by low concentrations of ambient GABA. Extrasynaptic GABA(A) receptors are composed of receptor subunits that convey biophysical properties ideally suited to the generation of persistent inhibition and are pharmacologically and functionally distinct from their synaptic counterparts. This mini-symposium review highlights ongoing work examining the properties of recombinant and native extrasynaptic GABA(A) receptors and their preferential targeting by endogenous and clinically relevant agents. In addition, it emphasizes the important role of extrasynaptic GABA(A) receptors in GABAergic inhibition throughout the CNS and identifies them as a major player in both physiological and pathophysiological processes.</description><identifier>ISSN: 0270-6474</identifier><identifier>EISSN: 1529-2401</identifier><identifier>DOI: 10.1523/JNEUROSCI.3340-09.2009</identifier><identifier>PMID: 19828786</identifier><language>eng</language><publisher>United States: Soc Neuroscience</publisher><subject>Animals ; Biophysical Phenomena - drug effects ; Biophysical Phenomena - physiology ; Central Nervous System - drug effects ; Central Nervous System - physiology ; Female ; gamma-Aminobutyric Acid - metabolism ; gamma-Aminobutyric Acid - pharmacology ; Humans ; Male ; Neural Inhibition - drug effects ; Neural Inhibition - physiology ; Pregnancy ; Presynaptic Terminals - drug effects ; Presynaptic Terminals - metabolism ; Protein Subunits - physiology ; Receptors, GABA-A - physiology ; Symposia and Mini-Symposia ; Synaptic Transmission - drug effects ; Synaptic Transmission - physiology</subject><ispartof>The Journal of neuroscience, 2009-10, Vol.29 (41), p.12757-12763</ispartof><rights>Copyright © 2009 Society for Neuroscience 0270-6474/09/2912757-07$15.00/0 2009</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2784229/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2784229/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19828786$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Belelli, Delia</creatorcontrib><creatorcontrib>Harrison, Neil L</creatorcontrib><creatorcontrib>Maguire, Jamie</creatorcontrib><creatorcontrib>Macdonald, Robert L</creatorcontrib><creatorcontrib>Walker, Matthew C</creatorcontrib><creatorcontrib>Cope, David W</creatorcontrib><title>Extrasynaptic GABAA Receptors: Form, Pharmacology, and Function</title><title>The Journal of neuroscience</title><addtitle>J Neurosci</addtitle><description>GABA is the principal inhibitory neurotransmitter in the CNS and acts via GABA(A) and GABA(B) receptors. Recently, a novel form of GABA(A) receptor-mediated inhibition, termed "tonic" inhibition, has been described. Whereas synaptic GABA(A) receptors underlie classical "phasic" GABA(A) receptor-mediated inhibition (inhibitory postsynaptic currents), tonic GABA(A) receptor-mediated inhibition results from the activation of extrasynaptic receptors by low concentrations of ambient GABA. Extrasynaptic GABA(A) receptors are composed of receptor subunits that convey biophysical properties ideally suited to the generation of persistent inhibition and are pharmacologically and functionally distinct from their synaptic counterparts. This mini-symposium review highlights ongoing work examining the properties of recombinant and native extrasynaptic GABA(A) receptors and their preferential targeting by endogenous and clinically relevant agents. In addition, it emphasizes the important role of extrasynaptic GABA(A) receptors in GABAergic inhibition throughout the CNS and identifies them as a major player in both physiological and pathophysiological processes.</description><subject>Animals</subject><subject>Biophysical Phenomena - drug effects</subject><subject>Biophysical Phenomena - physiology</subject><subject>Central Nervous System - drug effects</subject><subject>Central Nervous System - physiology</subject><subject>Female</subject><subject>gamma-Aminobutyric Acid - metabolism</subject><subject>gamma-Aminobutyric Acid - pharmacology</subject><subject>Humans</subject><subject>Male</subject><subject>Neural Inhibition - drug effects</subject><subject>Neural Inhibition - physiology</subject><subject>Pregnancy</subject><subject>Presynaptic Terminals - drug effects</subject><subject>Presynaptic Terminals - metabolism</subject><subject>Protein Subunits - physiology</subject><subject>Receptors, GABA-A - physiology</subject><subject>Symposia and Mini-Symposia</subject><subject>Synaptic Transmission - drug effects</subject><subject>Synaptic Transmission - physiology</subject><issn>0270-6474</issn><issn>1529-2401</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNpVkMtOwzAQRS0EgvL4BZQVYkGKPXH8YAEqVQtFiCIea2vquk1QEpc4pfTviURBsJrFPTr3agg5ZrTLUkjO7x4Gr0_j5_6omyScxlR3gVK9RTptqmPglG2TDgVJY8El3yP7IbxRSiVlcpfsMa1ASSU65Grw2dQY1hUumtxGN73rXi96ctYtGl-Hi2jo6_IsesywLtH6ws_XZxFW02i4rGyT--qQ7MywCO5ocw_I63Dw0r-N78c3o37vPs6AQRMLjVyombSSSZmiEsAVwwQchdRhCjhNtUpRKJR0YjnaxCKqmUo5oHDSJQfk8tu7WE5KN7WuamcXZlHnJdZr4zE3_5Mqz8zcfxiQigPoVnCyEdT-felCY8o8WFcUWDm_DEZIoTmFpAWP_zb9Vvz8rAVOv4Esn2ervHYmlFgULc7MarUCbTgzDGQqky_0TX24</recordid><startdate>20091014</startdate><enddate>20091014</enddate><creator>Belelli, Delia</creator><creator>Harrison, Neil L</creator><creator>Maguire, Jamie</creator><creator>Macdonald, Robert L</creator><creator>Walker, Matthew C</creator><creator>Cope, David W</creator><general>Soc Neuroscience</general><general>Society for Neuroscience</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20091014</creationdate><title>Extrasynaptic GABAA Receptors: Form, Pharmacology, and Function</title><author>Belelli, Delia ; Harrison, Neil L ; Maguire, Jamie ; Macdonald, Robert L ; Walker, Matthew C ; Cope, David W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-h212t-69a468f7c71775a862481a32e025ea52ad5985a68a70bc4ac3caa8f8542a6e7e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Animals</topic><topic>Biophysical Phenomena - drug effects</topic><topic>Biophysical Phenomena - physiology</topic><topic>Central Nervous System - drug effects</topic><topic>Central Nervous System - physiology</topic><topic>Female</topic><topic>gamma-Aminobutyric Acid - metabolism</topic><topic>gamma-Aminobutyric Acid - pharmacology</topic><topic>Humans</topic><topic>Male</topic><topic>Neural Inhibition - drug effects</topic><topic>Neural Inhibition - physiology</topic><topic>Pregnancy</topic><topic>Presynaptic Terminals - drug effects</topic><topic>Presynaptic Terminals - metabolism</topic><topic>Protein Subunits - physiology</topic><topic>Receptors, GABA-A - physiology</topic><topic>Symposia and Mini-Symposia</topic><topic>Synaptic Transmission - drug effects</topic><topic>Synaptic Transmission - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Belelli, Delia</creatorcontrib><creatorcontrib>Harrison, Neil L</creatorcontrib><creatorcontrib>Maguire, Jamie</creatorcontrib><creatorcontrib>Macdonald, Robert L</creatorcontrib><creatorcontrib>Walker, Matthew C</creatorcontrib><creatorcontrib>Cope, David W</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Journal of neuroscience</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Belelli, Delia</au><au>Harrison, Neil L</au><au>Maguire, Jamie</au><au>Macdonald, Robert L</au><au>Walker, Matthew C</au><au>Cope, David W</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Extrasynaptic GABAA Receptors: Form, Pharmacology, and Function</atitle><jtitle>The Journal of neuroscience</jtitle><addtitle>J Neurosci</addtitle><date>2009-10-14</date><risdate>2009</risdate><volume>29</volume><issue>41</issue><spage>12757</spage><epage>12763</epage><pages>12757-12763</pages><issn>0270-6474</issn><eissn>1529-2401</eissn><abstract>GABA is the principal inhibitory neurotransmitter in the CNS and acts via GABA(A) and GABA(B) receptors. Recently, a novel form of GABA(A) receptor-mediated inhibition, termed "tonic" inhibition, has been described. Whereas synaptic GABA(A) receptors underlie classical "phasic" GABA(A) receptor-mediated inhibition (inhibitory postsynaptic currents), tonic GABA(A) receptor-mediated inhibition results from the activation of extrasynaptic receptors by low concentrations of ambient GABA. Extrasynaptic GABA(A) receptors are composed of receptor subunits that convey biophysical properties ideally suited to the generation of persistent inhibition and are pharmacologically and functionally distinct from their synaptic counterparts. This mini-symposium review highlights ongoing work examining the properties of recombinant and native extrasynaptic GABA(A) receptors and their preferential targeting by endogenous and clinically relevant agents. In addition, it emphasizes the important role of extrasynaptic GABA(A) receptors in GABAergic inhibition throughout the CNS and identifies them as a major player in both physiological and pathophysiological processes.</abstract><cop>United States</cop><pub>Soc Neuroscience</pub><pmid>19828786</pmid><doi>10.1523/JNEUROSCI.3340-09.2009</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0270-6474
ispartof The Journal of neuroscience, 2009-10, Vol.29 (41), p.12757-12763
issn 0270-6474
1529-2401
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2784229
source PubMed (Medline)
subjects Animals
Biophysical Phenomena - drug effects
Biophysical Phenomena - physiology
Central Nervous System - drug effects
Central Nervous System - physiology
Female
gamma-Aminobutyric Acid - metabolism
gamma-Aminobutyric Acid - pharmacology
Humans
Male
Neural Inhibition - drug effects
Neural Inhibition - physiology
Pregnancy
Presynaptic Terminals - drug effects
Presynaptic Terminals - metabolism
Protein Subunits - physiology
Receptors, GABA-A - physiology
Symposia and Mini-Symposia
Synaptic Transmission - drug effects
Synaptic Transmission - physiology
title Extrasynaptic GABAA Receptors: Form, Pharmacology, and Function
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T04%3A42%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Extrasynaptic%20GABAA%20Receptors:%20Form,%20Pharmacology,%20and%20Function&rft.jtitle=The%20Journal%20of%20neuroscience&rft.au=Belelli,%20Delia&rft.date=2009-10-14&rft.volume=29&rft.issue=41&rft.spage=12757&rft.epage=12763&rft.pages=12757-12763&rft.issn=0270-6474&rft.eissn=1529-2401&rft_id=info:doi/10.1523/JNEUROSCI.3340-09.2009&rft_dat=%3Cproquest_pubme%3E67694023%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-h212t-69a468f7c71775a862481a32e025ea52ad5985a68a70bc4ac3caa8f8542a6e7e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=67694023&rft_id=info:pmid/19828786&rfr_iscdi=true